These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 36466748)

  • 1. Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States - Understanding the transition to adaptive, ultra-hypofractionated treatments.
    Chuong MD; Clark MA; Henke LE; Kishan AU; Portelance L; Parikh PJ; Bassetti MF; Nagar H; Rosenberg SA; Mehta MP; Refaat T; Rineer JM; Smith A; Seung S; Zaki BI; Fuss M; Mak RH
    Clin Transl Radiat Oncol; 2023 Jan; 38():161-168. PubMed ID: 36466748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical adoption patterns of 0.35 Tesla MR-guided radiation therapy in Europe and Asia.
    Slotman BJ; Clark MA; Özyar E; Kim M; Itami J; Tallet A; Debus J; Pfeffer R; Gentile P; Hama Y; Andratschke N; Riou O; Camilleri P; Belka C; Quivrin M; Kim B; Pedersen A; van Overeem Felter M; Kim YI; Kim JH; Fuss M; Valentini V
    Radiat Oncol; 2022 Aug; 17(1):146. PubMed ID: 35996192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First 500 Fractions Delivered with a Magnetic Resonance-guided Radiotherapy System: Initial Experience.
    Sahin B; Zoto Mustafayev T; Gungor G; Aydin G; Yapici B; Atalar B; Ozyar E
    Cureus; 2019 Dec; 11(12):e6457. PubMed ID: 32025388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic Magnetic Resonance-Guided Adaptive and Non-Adaptive Radiotherapy on Combination MR-Linear Accelerators: Current Practice and Future Directions.
    Bryant JM; Weygand J; Keit E; Cruz-Chamorro R; Sandoval ML; Oraiqat IM; Andreozzi J; Redler G; Latifi K; Feygelman V; Rosenberg SA
    Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT).
    Wolfe S; Diven MA; Marciscano AE; Zhou XK; Kishan AU; Steinberg ML; Miccio JA; Camilleri P; Nagar H
    BMC Cancer; 2023 Sep; 23(1):923. PubMed ID: 37777738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
    Hoegen P; Zhang KS; Tonndorf-Martini E; Weykamp F; Regnery S; Naumann P; Lang K; Ristau J; Körber SA; Dreher C; Buchele C; Rippke C; Renkamp CK; Paul KM; König L; Büsch C; Krisam J; Sedlaczek O; Schlemmer HP; Niyazi M; Corradini S; Debus J; Klüter S; Hörner-Rieber J
    Radiat Oncol; 2022 Mar; 17(1):59. PubMed ID: 35346270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial clinical experience with magnetic resonance-guided radiotherapy in pediatric patients: Lessons learned from a single institution with proton therapy.
    Hall MD; Mittauer KE; Herrera R; Von Werne K; Kotecha R; Kalman NS; McCulloch J; Alvarez D; McAllister NC; Doty DG; Rzepczynski AE; Deere W; Gutierrez AN; Chuong MD
    Front Oncol; 2022; 12():1037674. PubMed ID: 36713501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks versus 2 weeks (SHORTER).
    Marciscano AE; Wolfe S; Zhou XK; Barbieri CE; Formenti SC; Hu JC; Molina AM; Nanus DM; Nauseef JT; Scherr DS; Sternberg CN; Tagawa ST; Nagar H
    BMC Cancer; 2023 Aug; 23(1):781. PubMed ID: 37608258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of Adaptive MR-guided Stereotactic Body Radiotherapy (SBRT) of Lung Tumors.
    Padgett KR; Simpson GN; Llorente R; Samuels MA; Dogan N
    Cureus; 2018 Apr; 10(4):e2423. PubMed ID: 29872603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transition of Online Adaptive Stereotactic Radiotherapy for Pancreatic Cancer From Magnetic Resonance-Guided Linear Accelerator (MR-Linac) to State-of-the-Art Cone-Beam Computed Tomography (CBCT).
    Rechner LA; Felter M; Bekke S; Biancardo S; Rønjom MF; Pedersen M; Sjöström D; Chen IM; Sibolt P
    Cureus; 2024 Sep; 16(9):e68386. PubMed ID: 39355470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Silico Trial of MR-Guided Midtreatment Adaptive Planning for Hypofractionated Stereotactic Radiation Therapy in Centrally Located Thoracic Tumors.
    Henke LE; Kashani R; Hilliard J; DeWees TA; Curcuru A; Przybysz D; Green O; Robinson CG; Bradley JD
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):987-995. PubMed ID: 29953910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial Clinical Experience of MR-Guided Radiotherapy for Non-Small Cell Lung Cancer.
    Crockett CB; Samson P; Chuter R; Dubec M; Faivre-Finn C; Green OL; Hackett SL; McDonald F; Robinson C; Shiarli AM; Straza MW; Verhoeff JJC; Werner-Wasik M; Vlacich G; Cobben D
    Front Oncol; 2021; 11():617681. PubMed ID: 33777759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultra-Hypofractionated Prostate Radiotherapy With Online Adaptive Technique: A Case Report.
    Yoganathan SA; Riyas M; Sukumaran R; Hammoud R; Al-Hammadi N
    Cureus; 2024 Jul; 16(7):e64101. PubMed ID: 39114185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of On-Table Plan Adaptation in MR-Guided Ablative Radiation Therapy for Central Lung Tumors.
    Finazzi T; Palacios MA; Spoelstra FOB; Haasbeek CJA; Bruynzeel AME; Slotman BJ; Lagerwaard FJ; Senan S
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):933-941. PubMed ID: 30928360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CT-guided online adaptive stereotactic body radiotherapy for pancreas ductal adenocarcinoma: Dosimetric and initial clinical experience.
    Lee A; Pasetsky J; Lavrova E; Wang YF; Sedor G; Li FL; Gallitto M; Garrett M; Elliston C; Price M; Kachnic LA; Horowitz DP
    Clin Transl Radiat Oncol; 2024 Sep; 48():100813. PubMed ID: 39149753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementing cone-beam computed tomography-guided online adaptive radiotherapy in cervical cancer.
    Shelley CE; Bolt MA; Hollingdale R; Chadwick SJ; Barnard AP; Rashid M; Reinlo SC; Fazel N; Thorpe CR; Stewart AJ; South CP; Adams EJ
    Clin Transl Radiat Oncol; 2023 May; 40():100596. PubMed ID: 36910024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CT-Guided Online Adaptive Radiotherapy Delivered via Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR) for a Bulky Thoracic and Abdominal Mass in Oligometastatic Renal Cell Carcinoma.
    Kassardjian AA; Ladbury C; Maraghechi B; Shi C; Watkins T; Liu A; Tsai K; Williams T; Li YR; Dandapani S; Schwer A; Lee P
    Cureus; 2024 Aug; 16(8):e67502. PubMed ID: 39310403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-Driven Activity-Based Costing of CT-Guided vs MR-Guided Prostate SBRT.
    Parikh NR; Clark MA; Patel P; Kafka-Peterson K; Zaide L; Ma TM; Steinberg ML; Cao M; Raldow AC; Lamb J; Kishan AU
    Appl Radiat Oncol; 2021 Sep; 10(3):33-40. PubMed ID: 34671700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI-Guided Online Adaptive Stereotactic Body Radiation Therapy of Liver and Pancreas Tumors on an MR-Linac System.
    Stanescu T; Shessel A; Carpino-Rocca C; Taylor E; Semeniuk O; Li W; Barry A; Lukovic J; Dawson L; Hosni A
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beginning of clinical treatment using the 1.5 Tesla MR-Linac system in Japan: a narrative review.
    Takahashi N; Tanaka S; Umezawa R; Yamamoto T; Suzuki Y; Kishida K; Omata S; Arai K; Katsuta Y; Kadoya N; Jingu K
    Transl Cancer Res; 2024 Feb; 13(2):1131-1138. PubMed ID: 38482421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.